Plunkett Research Online: Anixa Biosciences Inc

ANIXA BIOSCIENCES INC (ANIX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ITUS Corp is a U.S based company engaged in funding, developing, acquiring, and licensing emerging technologies in the areas of biotechnology. The company, through its subsidiary, is developing a platform for non-invasive blood tests for the early detection of cancer......



Anixa Biosciences Inc
Ticker: ANIX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 408 708-9808
Fax:
Address: 3150 Almaden Expressway
Suite 250
San Jose, CA 95118 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Testing Laboratories, Safety and Compliance Services
ContactsDescription

Amit KumarCEO/Chairman of the Board/Director/President
Michael CatelaniCFO/Chief Accounting Officer/COO
See More
ITUS Corp is a U.S based company engaged in funding, developing, acquiring, and licensing emerging technologies in the areas of biotechnology. The company, through its subsidiary, is developing a platform for non-invasive blood tests for the early detection of cancer......See More See More

Auditor: Haskell & White LLP
Legal Advisor: Duane Morris LLP
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: